After surviving asthma as a child, the author explores whether parasitic worms—once a natural part of our gut biome—might ...

Liberals win close seat as ousted MP hints at comeback Deflated renter says cost of rent for tiny studio apartment 'is insane ...

National Institutes of Health (NIH) scientists report that a first-in-human clinical trial of a new therapy based on the ...

This patient perspectives interview features Stacy Courtnay, who shared her experience managing rheumatoid arthritis during pregnancy.

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

The biotech startup, a spinout of the University of Colorado Anschutz Medical Campus, launched this year with $15 million in ...

Incyte's stock valuation is on the higher side given looming patent expiries for Jakafi and Opzelura, and uncertain pipeline ...

To confirm the presence of the RA. To determine how active the disease is. The doctor and healthcare team use the results of these tests to guide treatment options for each patient. In turn, ...

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...